James Carbonara | Hayden IR |
Jennifer Simpson | Chief Executive Officer |
Sue Horvath | Chief Financial Officer |
Jonathan Aschoff | ROTH MKM |
Good day, everyone. And welcome to the Panbela Therapeutics Fourth Quarter 2022 Earnings Call. At this time, all participants have been placed on a listen-only mode, and we will open the floor for your questions-and-comments after the presentation.
It is now my pleasure to turn the floor over to your host, James Carbonara. Sir, the floor is yours.